Compare AXSM & BVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AXSM | BVN |
|---|---|---|
| Founded | 2012 | 1953 |
| Country | United States | Peru |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Mining |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 6.4B |
| IPO Year | 2015 | 1996 |
| Metric | AXSM | BVN |
|---|---|---|
| Price | $146.62 | $27.85 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 20 | 1 |
| Target Price | ★ $176.00 | $27.00 |
| AVG Volume (30 Days) | 526.6K | ★ 1.4M |
| Earning Date | 11-03-2025 | 10-30-2025 |
| Dividend Yield | N/A | ★ 1.04% |
| EPS Growth | N/A | ★ 20.28 |
| EPS | N/A | ★ 1.70 |
| Revenue | $561,263,000.00 | ★ $1,407,837,000.00 |
| Revenue This Year | $66.20 | $28.79 |
| Revenue Next Year | $57.56 | $14.32 |
| P/E Ratio | ★ N/A | $16.43 |
| Revenue Growth | ★ 65.83 | 26.97 |
| 52 Week Low | $75.56 | $11.50 |
| 52 Week High | $152.94 | $28.80 |
| Indicator | AXSM | BVN |
|---|---|---|
| Relative Strength Index (RSI) | 54.38 | 70.71 |
| Support Level | $144.13 | $24.63 |
| Resistance Level | $150.00 | $25.95 |
| Average True Range (ATR) | 4.19 | 0.98 |
| MACD | -0.81 | 0.35 |
| Stochastic Oscillator | 45.68 | 80.68 |
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
Compania de Minas Buenaventura SAA is a Peruvian precious metals-producing company with experience in mine exploration, development, construction, and operation.